We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $13.1M invested in Aptevo Therapeutics in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11% less capital invested

Capital invested by funds: $14.8M → $13.1M (-$1.6M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$665K
Puts
Net Calls
+$665K
Net Calls Change
-$10K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$3.48M
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$2.08M
Renaissance Technologies
3
Renaissance Technologies
New York
$1.46M
Vanguard Group
4
Vanguard Group
Pennsylvania
$994K
SC
5
Sessa Capital
New York
$906K
PWAM
6
Park West Asset Management
California
$887K
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$827K
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$560K
WVP
9
Worth Venture Partners
New Jersey
$397K
BlackRock
10
BlackRock
New York
$271K
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$207K
Geode Capital Management
12
Geode Capital Management
Massachusetts
$127K
ARTA
13
A.R.T. Advisors
New York
$116K
UBS Group
14
UBS Group
Switzerland
$85K
BCM
15
Bridgeway Capital Management
Texas
$83K
VF
16
Virtu Financial
New York
$78K
CL
17
CSS LLC
Illinois
$77K
AG
18
Algert Global
California
$66K
QI
19
QS Investors
New York
$56K
BFM
20
Boothbay Fund Management
New York
$53K
Northern Trust
21
Northern Trust
Illinois
$53K
Bank of New York Mellon
22
Bank of New York Mellon
New York
$50K
ACA
23
Atlas Capital Advisors
Wyoming
$43.5K
HKAM
24
Horizon Kinetics Asset Management
New York
$33K
CSIC
25
Clifford Swan Investment Counsel
California
$24K